126 related articles for article (PubMed ID: 21820037)
1. A new human dyskerin isoform with cytoplasmic localization.
Angrisani A; Turano M; Paparo L; Di Mauro C; Furia M
Biochim Biophys Acta; 2011 Dec; 1810(12):1361-8. PubMed ID: 21820037
[TBL] [Abstract][Full Text] [Related]
2. Dyskerin: an essential pseudouridine synthase with multifaceted roles in ribosome biogenesis, splicing, and telomere maintenance.
Garus A; Autexier C
RNA; 2021 Dec; 27(12):1441-1458. PubMed ID: 34556550
[TBL] [Abstract][Full Text] [Related]
3. Severity of X-linked dyskeratosis congenita (DKCX) cellular defects is not directly related to dyskerin (DKC1) activity in ribosomal RNA biogenesis or mRNA translation.
Thumati NR; Zeng XL; Au HH; Jang CJ; Jan E; Wong JM
Hum Mutat; 2013 Dec; 34(12):1698-707. PubMed ID: 24115260
[TBL] [Abstract][Full Text] [Related]
4. Intron retention: a human DKC1 gene common splicing event.
Turano M; Angrisani A; Di Maio N; Furia M
Biochem Cell Biol; 2013 Dec; 91(6):506-12. PubMed ID: 24219293
[TBL] [Abstract][Full Text] [Related]
5. A functional connection between dyskerin and energy metabolism.
Angrisani A; Matrone N; Belli V; Vicidomini R; Di Maio N; Turano M; Scialò F; Netti PA; Porcellini A; Furia M
Redox Biol; 2018 Apr; 14():557-565. PubMed ID: 29132127
[TBL] [Abstract][Full Text] [Related]
6. Mouse dyskerin mutations affect accumulation of telomerase RNA and small nucleolar RNA, telomerase activity, and ribosomal RNA processing.
Mochizuki Y; He J; Kulkarni S; Bessler M; Mason PJ
Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10756-61. PubMed ID: 15240872
[TBL] [Abstract][Full Text] [Related]
7. Impaired Telomere Maintenance and Decreased Canonical WNT Signaling but Normal Ribosome Biogenesis in Induced Pluripotent Stem Cells from X-Linked Dyskeratosis Congenita Patients.
Gu BW; Apicella M; Mills J; Fan JM; Reeves DA; French D; Podsakoff GM; Bessler M; Mason PJ
PLoS One; 2015; 10(5):e0127414. PubMed ID: 25992652
[TBL] [Abstract][Full Text] [Related]
8. Human dyskerin: beyond telomeres.
Angrisani A; Vicidomini R; Turano M; Furia M
Biol Chem; 2014 Jun; 395(6):593-610. PubMed ID: 24468621
[TBL] [Abstract][Full Text] [Related]
9. Gene structure and expression of the mouse dyskeratosis congenita gene, dkc1.
Heiss NS; Bächner D; Salowsky R; Kolb A; Kioschis P; Poustka A
Genomics; 2000 Jul; 67(2):153-63. PubMed ID: 10903840
[TBL] [Abstract][Full Text] [Related]
10. Dyskeratosis congenita: a disorder of defective telomere maintenance?
Walne AJ; Marrone A; Dokal I
Int J Hematol; 2005 Oct; 82(3):184-9. PubMed ID: 16207588
[TBL] [Abstract][Full Text] [Related]
11. Dyskeratosis congenita mutations in dyskerin SUMOylation consensus sites lead to impaired telomerase RNA accumulation and telomere defects.
Brault ME; Lauzon C; Autexier C
Hum Mol Genet; 2013 Sep; 22(17):3498-507. PubMed ID: 23660516
[TBL] [Abstract][Full Text] [Related]
12. Dyskerin localizes to the nucleolus and its mislocalization is unlikely to play a role in the pathogenesis of dyskeratosis congenita.
Heiss NS; Girod A; Salowsky R; Wiemann S; Pepperkok R; Poustka A
Hum Mol Genet; 1999 Dec; 8(13):2515-24. PubMed ID: 10556300
[TBL] [Abstract][Full Text] [Related]
13. Acute telomerase components depletion triggers oxidative stress as an early event previous to telomeric shortening.
Ibáñez-Cabellos JS; Pérez-Machado G; Seco-Cervera M; Berenguer-Pascual E; García-Giménez JL; Pallardó FV
Redox Biol; 2018 Apr; 14():398-408. PubMed ID: 29055871
[TBL] [Abstract][Full Text] [Related]
14. Dyskeratosis congenita: molecular insights into telomerase function, ageing and cancer.
Marrone A; Dokal I
Expert Rev Mol Med; 2004 Dec; 6(26):1-23. PubMed ID: 15613268
[TBL] [Abstract][Full Text] [Related]
15. Pseudouridylation defect due to
Balogh E; Chandler JC; Varga M; Tahoun M; Menyhárd DK; Schay G; Goncalves T; Hamar R; Légrádi R; Szekeres Á; Gribouval O; Kleta R; Stanescu H; Bockenhauer D; Kerti A; Williams H; Kinsler V; Di WL; Curtis D; Kolatsi-Joannou M; Hammid H; Szőcs A; Perczel K; Maka E; Toldi G; Sava F; Arrondel C; Kardos M; Fintha A; Hossain A; D'Arco F; Kaliakatsos M; Koeglmeier J; Mifsud W; Moosajee M; Faro A; Jávorszky E; Rudas G; Saied MH; Marzouk S; Kelen K; Götze J; Reusz G; Tulassay T; Dragon F; Mollet G; Motameny S; Thiele H; Dorval G; Nürnberg P; Perczel A; Szabó AJ; Long DA; Tomita K; Antignac C; Waters AM; Tory K
Proc Natl Acad Sci U S A; 2020 Jun; 117(26):15137-15147. PubMed ID: 32554502
[TBL] [Abstract][Full Text] [Related]
16. Accelerated hematopoietic stem cell aging in a mouse model of dyskeratosis congenita responds to antioxidant treatment.
Gu BW; Fan JM; Bessler M; Mason PJ
Aging Cell; 2011 Apr; 10(2):338-48. PubMed ID: 21241452
[TBL] [Abstract][Full Text] [Related]
17. SUMOylation- and GAR1-Dependent Regulation of Dyskerin Nuclear and Subnuclear Localization.
MacNeil DE; Lambert-Lanteigne P; Qin J; McManus FP; Bonneil E; Thibault P; Autexier C
Mol Cell Biol; 2021 Mar; 41(4):. PubMed ID: 33526451
[TBL] [Abstract][Full Text] [Related]
18. Dyskeratosis congenita: a genetic disorder of many faces.
Kirwan M; Dokal I
Clin Genet; 2008 Feb; 73(2):103-12. PubMed ID: 18005359
[TBL] [Abstract][Full Text] [Related]
19. Effects of dyskeratosis congenita mutations in dyskerin, NHP2 and NOP10 on assembly of H/ACA pre-RNPs.
Trahan C; Martel C; Dragon F
Hum Mol Genet; 2010 Mar; 19(5):825-36. PubMed ID: 20008900
[TBL] [Abstract][Full Text] [Related]
20. DKC1 overexpression associated with prostate cancer progression.
Sieron P; Hader C; Hatina J; Engers R; Wlazlinski A; Müller M; Schulz WA
Br J Cancer; 2009 Oct; 101(8):1410-6. PubMed ID: 19755982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]